发明名称 Gastroretentive, extended release composition of therapeutic agent
摘要 A gastroretentive, extended release composition which floats and swells at acidic pH prevalent in the stomach. The composition includes a pH dependent graft copolymer, a gellable polymer, a therapeutic agent, a gas generating system and pharmaceutically acceptable ingredients. The disclosed composition is useful to deliver the therapeutic agent within the stomach for an extended period of time.
申请公布号 US8808669(B2) 申请公布日期 2014.08.19
申请号 US201213608994 申请日期 2012.09.10
申请人 Council of Scientific & Industrial Research 发明人 Muthusamy Ramesh;Kulkarni Mohan Gopalkrishna
分类号 A61K47/34;A61K31/496;A61K31/5383;A61K31/554;A61P31/04;A61P9/00;A61P3/02;A61K31/675;A61K47/38;A61K31/545;A61K9/20;A61K9/00;A61K31/525 主分类号 A61K47/34
代理机构 St. Onge Steward Johnston & Reens LLC 代理人 St. Onge Steward Johnston & Reens LLC
主权项 1. A gastroretentive, extended release composition for oral administration comprising: a. a graft copolymer of formula 1 which exhibits pH dependent behavior and capable of swelling at acidic pH, represented by  wherein the said graft copolymer comprises: I. a backbone having the formula [A(x) B(y) C(z)] comprising: a diol (A) selected from the group consisting of 1,2-ethane diol, 1,3-propane diol, 1,2-propane diol, 2-methyl-1,3-propane diol, 1,4-butane diol, 1,3-butane diol, 1,2-butane diol, 1,5-pentane diol, 1,6-hexane diol, 1,7-heptane diol, 1,8-octane diol, 1,9-nonane diol, 1,12-dodecane diol, 1,4-cyclohexanedimethanol and bis(2-hydroxyethyl)terephthalate,a dicarboxylic acid (B) selected from the group consisting of succinic acid, glutaric acid, adipic acid, pimelic acid, suberic acid, azelaic acid, sebacic acid, and dodecanedioic acid or acid anhydride (B) selected from the group consisting of succinic anhydride and phthalic anhydride andan epoxy monomer (C) containing pendant unsaturation selected from the group consisting of glycidyl methacrylate and glycidyl acrylate or a diol monomer (C) containing pendant unsaturation selected from the group consisting of trimethylolpropane monomethacrylate and trimethylolpropane monoacrylate,wherein (x)=41-45%, (y)=49-53% (z)=4-7% by mole; and II. a graft which is a polymer of a vinyl pyridine monomer (D) and ‘w’ is a weight percent of the total weight of said graft copolymer such that ‘w’ is 22-52%; b. a gellable polymer, said gellable polymer selected from the group consisting of cellulosic polymers and polyalkene oxide; c. a therapeutically active agent; d. a gas generating system, said gas generating system comprising a gas generating agent and a carboxyl compound, said gas generating agent selected from the group consisting of alkali carbonates and bicarbonates; and e. pharmaceutically acceptable ingredients.
地址 IN